• Navigation
  • Register My DNA Kit
  • Features
  • Pricing
  • FAQ
  • About
  • Labs
  • Login
  • Get started
  1. Home
  2. Genes
  3. OPRM1

OPRM1 (Opioid receptor mu 1)

Loading...

Summary of OPRM1

Activation of the mu receptor by a substance such as morphine causes sedation, euphoria and decreased respiration (R).

Individual differences in the function of the mu-receptor system predict personality traits that confer vulnerability to or resiliency against risky behaviors such as the predisposition to develop substance use disorders (R). Activating opioid receptors promote eating and weight gain, at least in the short term (R).

0 users want this gene increased, 0 users want it decreased

The Function of OPRM1

Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors. The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extend to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15. They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B. Also couples to adenylate cyclase stimulatory G alpha proteins. The selective temporal coupling to G-proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4. Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization. Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G-protein thus terminating signal transduction. The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins. The activation of the ERK pathway occurs either in a G-protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation. Acts as a class A G-protein coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling. Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G-protein coupling. Endogenous ligands induce rapid desensitization, endocytosis and recycling whereas morphine induces only low desensitization and endocytosis. Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties. Involved in neurogenesis. Isoform 12 couples to GNAS and is proposed to be involved in excitatory effects. Isoform 16 and isoform 17 do not bind agonists but may act through oligomerization with binding-competent OPRM1 isoforms and reduce their ligand binding activity.

Protein names

Recommended name:

Mu-type opioid receptor

Short name:

MOP

Alternative name(s):

M-OR-1
MOR-1
Mu opiate receptor
Mu opioid receptor
hMOP

OPRM1 SNPs

    To see your genotype, you should be logged in and have a file with your genotype uploaded.

  1. RS10485057 (OPRM1) ??
  2. RS1799971 (OPRM1) ??
  3. RS1799972 (OPRM1) ??
  4. RS2075572 (OPRM1) ??
  5. RS2236256 (OPRM1) ??
  6. RS3778151 (OPRM1) ??
  7. RS3823010 (OPRM1) ??
  8. RS538174 (OPRM1) ??
  9. RS540825 (OPRM1) ??
  10. RS563649 (OPRM1) ??
  11. RS675026 (OPRM1) ??
  12. RS9384179 (OPRM1) ??

Top Gene-Substance Interactions

OPRM1 Interacts with These Diseases

Disease Score

Fixes

Natural Ways to Increase Opioid Activity

All of these give us a positive feeling, and at least some of it is because of the opioid system in our body. The following either increase activation of our mu opioid receptors, increase endorphins, which naturally activate our mu-opioid receptors, or make our receptors more sensitive.

  • Cold (R),
  • High-intensity exercise (R, R2)
  • Sleep (R)
  • Sun/UVB (R, R2)
  • Warm showers (R)
  • Social interaction (R)
  • Massages (R)
  • Palatable foods (R,R2)
  • Acupuncture (R)
  • Magnesium (R, R2)
  • Butyrate (R)
  • Capsaicin/Chilli (R)
  • Acidophilus (R)
  • Melatonin (R)

Fixes Advanced

These are advanced ways to activate the mu-opioid receptor:

  • LLLT (R)
  • Low dose naltrexones (R).
  • Oxytocin (R)
  • Nicotine (R)
  • Marijuana - THC/CBD (R)
  • Poppy Seeds (R)
  • Pregnenolone (R)
  • Kratom (R)
  • tDCS (R)

Not recommended to activate the mu-opioid receptor:

  • Alcohol (R)
  • Stress (R)

Substances That Increase OPRM1

Substances Interaction Organism Category

Substances That Decrease OPRM1

Substances Interaction Organism Category

Advanced Summary

Activation of the mu receptor by a substance such as morphine causes sedation, euphoria and decreased respiration (R). Although morphine increases sedation, it decreases the total amount of deep sleep and rapid eye movement sleep in humans. (R).

Individual differences in the function of the mu-receptor system predict personality traits that confer vulnerability to or resiliency against risky behaviors such as the predisposition to develop substance use disorders (R).

Activating opioid receptors promote eating and weight gain, at least in the short term (R). When fed a high-fat diet, mice without mu-opioid receptors were resistant to obesity, despite having similar calorie intake to normal mice fed a high-fat diet. This resistance to obesity with the mutant mouse without mu-opioid receptors was associated with increased fatty acid oxidation within muscles (R).

When food proteins are digested, they produce peptides that block mu-opioid activity. These peptides are released in the vein that brings blood flow to the gut.

The vagus nerves communicate with the brain initiate satiety as a result of the mu-opioid blocking (as a result of sensing gut gluconeogenesis) (R). This is one reason why a protein rich diet aids in weight loss.

When the mice were switched from a starch- to a protein-enriched diet, mice reduced their food intake by about 20%, but no such effect occurred in the mice lacking the mu-opioid receptors (R).

Conditions with Increased Gene Activity

Condition Change (log2fold) Comparison Species Experimental variables Experiment name

Conditions with Decreased Gene Activity

Condition Change (log2fold) Comparison Species Experimental variables Experiment name

Technical

The following transcription factors affect gene expression:

  • STAT3
  • STAT1
  • STAT1beta
  • STAT1alpha

Tissue specificity:

Expressed in brain. Isoform 16 and isoform 17 are detected in brain.

Gene Pathways:

  • Signal Transduction
  • Neuroactive ligand-receptor interaction

Molecular Function:

  • Beta-Endorphin Receptor Activity
  • G-Protein Alpha-Subunit Binding
  • G-Protein Beta-Subunit Binding
  • G-Protein Coupled Receptor Activity
  • Morphine Receptor Activity
  • Neuropeptide Binding
  • Voltage-Gated Calcium Channel Activity

Biological Processes:

  • Acute Inflammatory Response To Antigenic Stimulus
  • Adenylate Cyclase-Activating Dopamine Receptor Signaling Pathway
  • Adenylate Cyclase-Inhibiting Opioid Receptor Signaling Pathway
  • Behavioral Response To Ethanol
  • Cellular Response To Morphine
  • Cellular Response To Stress
  • Chemical Synaptic Transmission
  • Eating Behavior
  • Estrous Cycle
  • Excitatory Postsynaptic Potential
  • G-Protein Coupled Receptor Signaling Pathway, Coupled To Cyclic Nucleotide Second Messenger
  • Locomotory Behavior
  • Negative Regulation Of Adenylate Cyclase Activity
  • Negative Regulation Of Camp-Mediated Signaling
  • Negative Regulation Of Cell Proliferation
  • Negative Regulation Of Cytosolic Calcium Ion Concentration
  • Negative Regulation Of Nitric Oxide Biosynthetic Process
  • Negative Regulation Of Wnt Protein Secretion
  • Phospholipase C-Activating G-Protein Coupled Receptor Signaling Pathway
  • Positive Regulation Of Appetite
  • Positive Regulation Of Camp-Mediated Signaling
  • Positive Regulation Of Cytosolic Calcium Ion Concentration
  • Positive Regulation Of Erk1 And Erk2 Cascade
  • Positive Regulation Of Neurogenesis
  • Positive Regulation Of Nitric Oxide Biosynthetic Process
  • Regulation Of N-Methyl-D-Aspartate Selective Glutamate Receptor Activity
  • Regulation Of Sensory Perception Of Pain
  • Response To Cocaine
  • Response To Food
  • Response To Growth Factor
  • Response To Lipopolysaccharide
  • Response To Radiation
  • Sensory Perception
  • Sensory Perception Of Pain
  • Wound Healing

Drug Bank:

  • Levomethadyl Acetate
  • Alvimopan
  • Amitriptyline
  • Anileridine
  • Butorphanol
  • Codeine
  • Dextromethorphan
  • Dextropropoxyphene
  • Dezocine
  • Diphenoxylate
  • Ethylmorphine
  • Fentanyl
  • Heroin
  • Hydrocodone
  • Hydromorphone
  • Ketamine
  • Levallorphan
  • Levorphanol
  • Loperamide
  • Methadone
  • Methadyl Acetate
  • Pethidine
  • Naloxegol
  • Naloxone
  • Naltrexone
  • Ondansetron
  • Oxymorphone
  • Pentazocine
  • Remifentanil
  • Sufentanil
  • Tapentadol
  • Methylnaltrexone
  • Alfentanil
  • Buprenorphine
  • Eluxadoline
  • Ketobemidone
  • Morphine
  • Nalbuphine
  • Oxycodone
  • Tramadol
*synonyms

Synonyms/Aliases/Alternative Names of the Gene:

hypothetical protein| MOP| A306_05644| Anapl_17823| AS27_14760| AS28_00568| CB1_000719001| D623_10023596| GW7_13378| H920_07303| I79_001179| LMOR| M959_02329| MDA_GLEAN10018817| MOP-R| MOP receptor| mor| MOR1| M-OR-1| MOR-1| MOR-1O| MORA| mu opiate receptor| mu opioid receptor| mu-opioid receptor| mu opioid receptor hMOR-1a| mu opioid receptor MOR-1BI| mu opioid receptor MOR-1P| mu opioid receptor splice variant mMOR-1Z| mu opioid receptor splice variant rMOR-1S| mu opioid receptor splice variant rMOR-1Z| muOR| MUOR1| mu-type opioid receptor| mu-type opioid receptor 1| Mu-type opioid receptor isoform 1-like protein| mu-type opioid receptor-like| N300_09648| N301_03888| N302_02927| N303_00667| N305_06987| N306_12174| N307_11523| N309_09499| N310_11623| N311_02467| N312_08056| N320_10826| N321_10554| N322_00078| N324_12000| N325_12528| N327_04071| N328_08929| N329_12239| N330_13444| N331_01962| N332_05237| N333_03199| N334_13140| N335_14472| N336_02900| N339_03880| N340_10640| N341_00193| opioid receptor B| opioid receptor, mu 1| opioid receptor MU-1| Oprm| Oprrm1| or2| ORM1| PAL_GLEAN10013144| PANDA_020749| TREES_T100017508| Y1Q_013139| Y956_00267| ZfMOR| ZFOR2| oprm1

Policies

  • Terms of Service
  • Platform Consent
  • Privacy Policy
  • Disclaimer

About

  • Customer Support
  • Our Team
  • Affiliate Program

Navigation

  • Homepage
  • DNA Wellness Reports
  • Personalized Genetics Blog
  • Register your DNA Test Kit
  • Login
  • Careers
GET STARTED
  • SelfDecode is a personalized health report service, which enables users to obtain detailed information and reports based on their genome. SelfDecode does not treat, diagnose or cure any conditions, but is for informational and educational purposes alone.
SelfDecode © 2021 All Rights Reserved